Read our most most exciting and recent news stories. If you are looking for an older news story, try our news archives.
Smartphone Solution Redefines Client Care
Technology North Corp. is one step closer to bringing its TN ActiveCare iPhone applications to assisted living organizations thanks to $200,000 in product development support from NRC-IRAP and the Alberta Innovates Technology Futures Voucher program to further prototype development.
IMBiotechnologies Receives FDA Clearance
IMBiotechnologies Ltd. ("IMBio"), a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration (FDA) to market its lead product, Occlusin(R) 500 Artificial Embolization Device (OCL 500) in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.
New Tool for Personalized Cancer Therapy
TEC Edmonton negotiates a licensing agreement between the University of Alberta and Clavis Pharma ASA, a Norwegian company that develops anti-cancer drugs, for an antibody which may be pivotal in the fight against cancer.
TEC VenturePrize winners for 2010
Alberta’s best emerging entrepreneurs came with one mission, to be TEC Edmonton’s VenturePrize winners. The battle was won by Biolithic for the Fast Growth award and Alberta Carbon for the Student Business Plan award. Listen to the Innovation Anthology interview.